Aevice Health, a pioneering MedTech spin-off from Nanyang Technological University based in Singapore, has successfully raised an impressive $2,100,000 in its latest funding round. This significant investment marks a vital step towards advancing the company鈥檚 mission of tackling chronic respiratory diseases, which represent one of the most pressing healthcare challenges faced by our generation. Known for its groundbreaking non-invasive wearable devices, Aevice Health offers solutions that allow for the early detection of cardiopulmonary abnormalities in patients, enabling remote and real-time monitoring of their health. This innovative approach not only facilitates swift and targeted care delivered right from the comfort of patients' homes but also enhances the ability of clinicians to obtain valuable insights into their patients' health and treatment responses through the Aevice analytical platform. With this fresh influx of capital, Aevice Health is poised to expand its research and development initiatives, enhancing its existing product offerings and accelerating the deployment of its life-changing technology in diverse healthcare settings. As the company continues to drive medical innovations that improve health outcomes and empower lives, it remains committed to ensuring that timely and accessible healthcare becomes a reality for more individuals grappling with chronic respiratory issues. For more information about how Aevice Health is revolutionizing patient care and monitoring, visit their website at www.aevice.com.








